Application

TASMAN PHARMA

Douglas Pharmaceuticals Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90237013
Filing Date: 10/06/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90237013
MARK INFORMATION
*MARK TASMAN PHARMA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TASMAN PHARMA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Douglas Pharmaceuticals Limited
*MAILING ADDRESS Central Park Drive
*CITY Lincoln, Auckland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY New Zealand
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
0610
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION New Zealand
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the prevention and treatment of psychiatric diseases and disorders, and oncological diseases and disorders
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
DISCLAIMER No claim is made to the exclusive right to use PHARMA apart from the mark as shown.
ATTORNEY INFORMATION
NAME Christopher D. Olszyk, Jr.
ATTORNEY DOCKET NUMBER 169573.00012
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Fox Rothschild LLP
STREET 997 Lenox Drive, Bldg. 3
CITY Lawrenceville
STATE New Jersey
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 08648-2311
PHONE 215-299-2081
FAX 609.896.1469
EMAIL ADDRESS ipdocket@foxrothschild.com
OTHER APPOINTED ATTORNEY Michael J. Leonard
CORRESPONDENCE INFORMATION
NAME Christopher D. Olszyk, Jr.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipdocket@foxrothschild.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) colszyk@foxrothschild.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /lisacraigie/
SIGNATORY'S NAME Lisa Craigie
SIGNATORY'S POSITION Head of US, EU & MENA
DATE SIGNED 10/06/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90237013
Filing Date: 10/06/2020

To the Commissioner for Trademarks:

MARK: TASMAN PHARMA (Standard Characters, see mark)
The literal element of the mark consists of TASMAN PHARMA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Douglas Pharmaceuticals Limited, a corporation of New Zealand, having an address of
      Central Park Drive
      Lincoln, Auckland 0610
      New Zealand
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the prevention and treatment of psychiatric diseases and disorders, and oncological diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Disclaimer
No claim is made to the exclusive right to use PHARMA apart from the mark as shown.


The owner's/holder's proposed attorney information: Christopher D. Olszyk, Jr.. Other appointed attorneys are Michael J. Leonard. Christopher D. Olszyk, Jr. of Fox Rothschild LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      997 Lenox Drive, Bldg. 3
      Lawrenceville, New Jersey 08648-2311
      United States
      215-299-2081(phone)
      609.896.1469(fax)
      ipdocket@foxrothschild.com
The docket/reference number is 169573.00012.
Christopher D. Olszyk, Jr. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Christopher D. Olszyk, Jr.
       PRIMARY EMAIL FOR CORRESPONDENCE: ipdocket@foxrothschild.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): colszyk@foxrothschild.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /lisacraigie/   Date: 10/06/2020
Signatory's Name: Lisa Craigie
Signatory's Position: Head of US, EU & MENA
Payment Sale Number: 90237013
Payment Accounting Date: 10/06/2020

Serial Number: 90237013
Internet Transmission Date: Tue Oct 06 08:38:25 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202010060838259
59616-90237013-750a52f9ecc93e8675e98a029
25b72ce7b8deb290e814f15ab298e2bd80c35aa0
-CC-38240354-20201005200612822137

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed